Amniotic Membrane Transplanted in Conjunctiva as a Mesenchymal Stem Cells Carrier for Limbal Stem Cell Deficiency

2011 ◽  
Vol 52 (9) ◽  
pp. 1104
Author(s):  
Tae Hyung Kim ◽  
Jae Hoon Jeong ◽  
Yeoun Sook Chun ◽  
Jae Chan Kim
2014 ◽  
Vol 163 (3) ◽  
pp. 200-210 ◽  
Author(s):  
Che Man Rohaina ◽  
Kong Yong Then ◽  
Angela Min Hwei Ng ◽  
Wan Haslina Wan Abdul Halim ◽  
Aida Zairani Mohd Zahidin ◽  
...  

2009 ◽  
Vol 89 (8) ◽  
pp. 741-748 ◽  
Author(s):  
Helga Reinshagen ◽  
Claudia Auw-Haedrich ◽  
Ruediger V. Sorg ◽  
Daniel Boehringer ◽  
Philipp Eberwein ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (9) ◽  
pp. 1134
Author(s):  
Julia I. Khorolskaya ◽  
Daria A. Perepletchikova ◽  
Daniel V. Kachkin ◽  
Kirill E. Zhurenkov ◽  
Elga I. Alexander-Sinkler ◽  
...  

The development of cell-based approaches to the treatment of various cornea pathologies, including limbal stem cell deficiency (LSCD), is an area of current interest in regenerative biomedicine. In this context, the shortage of donor material is urgent, and limbal mesenchymal stem cells (L-MSCs) may become a promising cell source for the development of these novel approaches, being established mainly within the rabbit model. In this study, we obtained and characterized rabbit L-MSCs and modified them with lentiviral transduction to express the green fluorescent protein EGFP (L-MSCs-EGFP). L-MSCs and L-MSCs-EGFP express not only stem cell markers specific for mesenchymal stem cells but also ABCG2, ABCB5, ALDH3A1, PAX6, and p63a specific for limbal epithelial stem cells (LESCs), as well as various cytokeratins (3/12, 15, 19). L-MSCs-EGFP have been proven to differentiate into adipogenic, osteogenic, and chondrogenic directions, as well as to transdifferentiate into epithelial cells. The possibility of using L-MSCs-EGFP to study the biocompatibility of various scaffolds developed to treat corneal pathologies was demonstrated. L-MSCs-EGFP may become a useful tool for studying regenerative processes occurring during the treatment of various corneal pathologies, including LSCD, with the use of cell-based technologies.


Ophthalmology ◽  
2003 ◽  
Vol 110 (8) ◽  
pp. 1585-1592 ◽  
Author(s):  
Mario A Meallet ◽  
Edgar M Espana ◽  
Martin Grueterich ◽  
Seng-Ei Ti ◽  
Eiki Goto ◽  
...  

2008 ◽  
Vol 145 (5) ◽  
pp. 787-794 ◽  
Author(s):  
Ahmad Kheirkhah ◽  
Victoria Casas ◽  
Vadrevu K. Raju ◽  
Scheffer C.G. Tseng

Ophthalmology ◽  
2012 ◽  
Vol 119 (5) ◽  
pp. 930-937 ◽  
Author(s):  
Philipp Eberwein ◽  
Daniel Böhringer ◽  
Johannes Schwartzkopff ◽  
Florian Birnbaum ◽  
Thomas Reinhard

Sign in / Sign up

Export Citation Format

Share Document